1. Home
  2. CALX vs ICUI Comparison

CALX vs ICUI Comparison

Compare CALX & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calix Inc

CALX

Calix Inc

HOLD

Current Price

$54.47

Market Cap

4.2B

ML Signal

HOLD

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$148.12

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CALX
ICUI
Founded
1999
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.6B
IPO Year
2010
1992

Fundamental Metrics

Financial Performance
Metric
CALX
ICUI
Price
$54.47
$148.12
Analyst Decision
Strong Buy
Buy
Analyst Count
5
5
Target Price
$77.75
$179.50
AVG Volume (30 Days)
799.0K
224.4K
Earning Date
01-28-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$933,685,000.00
$2,320,363,000.00
Revenue This Year
$21.58
N/A
Revenue Next Year
$13.35
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.89
N/A
52 Week Low
$28.61
$107.00
52 Week High
$71.22
$175.51

Technical Indicators

Market Signals
Indicator
CALX
ICUI
Relative Strength Index (RSI) 43.50 60.78
Support Level $52.72 $141.39
Resistance Level $56.60 $148.55
Average True Range (ATR) 1.68 3.56
MACD 0.27 -0.54
Stochastic Oscillator 42.09 77.08

Price Performance

Historical Comparison
CALX
ICUI

About CALX Calix Inc

Calix Inc develops, markets and sells its appliance-based platform, cloud and managed services that enable service providers of all types and sizes to innovate and transform their businesses. The company's customers utilize the real-time data and insights from Calix platforms to simplify their business and deliver experiences that excite their subscribers. The resulting growth in subscriber acquisition, loyalty and revenue creates more value for their businesses and communities. The Company's revenue is principally derived in the United States and it also has its presence in Middle East & Africa, Europe, Asia Pacific and other markets.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Share on Social Networks: